RankAlpha logo
Back to Rankings

ENTX

Entera BioB
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-06-02
View Chart
+
Peers tracked
10
U.S. public peers
Grade Position
Above peers
vs peer average
ENTX vs peer average
84/100
ENTX vs. peer average (B vs. D)
Grade spread
A 1 · C 2 · D 1 · F 6
Graded peers loaded
Coverage
10 graded
100% of tracked

Peer overview

ATOS is the first available peer comparator.

Loose same-sector, similar-market-cap biotech comparator from the packet; useful only for financing sensitivity and binary clinical-event volatility, not as a direct osteoporosis or oral-peptide peer.

✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
Top peerATOSAtossa Therapeutics
ENTX
Entera Bio
ATOS
Atossa Therapeutics
Grade
B
F
Momentum
91
2
Value
41
58
Sentiment
36
-
Setup Bias
Net Neutral
-
Market Cap
-
-
Posture
Constructive
Defensive
Open Side-by-Side ComparisonCompare all

Grade position vs ATOS

ENTX / ATOS
Grade Position
Above peers
ENTX vs. peer average (B vs. D)
84/100
Momentum
91
ENTX
Value
41
ATOS
Sentiment
36
-

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank
Ticker
Company
Grade
Grade score
vs ENTX
1
ATOS
ATOS
F
20/100
+3
2
PLRX
PLRX
A
100/100
-1
3
EDSA
Edesa Biotech Inc Common
C
60/100
+1
4
SCLX
Scilex Holding Co Common
F
20/100
+3
5
PMVP
PMV Pharmaceuticals Inc Common
D
40/100
+2
ATOS is the first peer returned for this comparison set.